Methamphetamine and Stimulant Use
Cocaine and methamphetamine use rates and overdose deaths are rapidly increasing across the United States. According to data from the CDC, overdose deaths from stimulants increased by 7.5 times between 2007 and 2017. The National Institute of Drug Abuse released a report on methamphetamine in April 2019. Read the report.
The New England ATTC offers several training and technical assistance products to build workforce capacity in this high priority area.
1) Stimulant Use Disorders: Epidemiology, Clinical Challenges, and Review of Treatments
This webinar reviews the rising prevalence of stimulant use disorders and discusses some of the unique clinical challenges presented by individuals who use stimulants. Evidence-based behavioral/psychosocial strategies are presented, along with pharmacotherapies currently considered promising. Presented by Dr. Richard Rawson.
2) Implementation of evidence-based treatments for methamphetamine dependence
This workshop provides a more in-depth view of evidence-based behavioral/psychosocial strategies for stimulant use disorder, and considers key principles associated with implementing these treatments in practice. Presented by Dr. Richard Rawson.
3) Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)
Patients receiving methadone or buprenorphine who misuse stimulants have unique treatment needs. In partnership with a NIDA-funded R01 (MPIs: Becker and Garner), the New England ATTC is helping opioid treatment programs throughout the region to implement contingency management, an evidence-based behavioral intervention for opioid use disorder that is also highly effective for patients with stimulant use disorder. Opioid treatment programs participating in Project MIMIC receive didactic training, performance feedback, and ongoing coaching. Programs interested in learning more about this technical assistance initiative should contact ProjectMIMIC@brown.edu